Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Colorcon
Baxter
McKesson
Merck

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

DRIXORAL Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for DRIXORAL
US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: 26
Formulation / Manufacturing:see details
DailyMed Link:DRIXORAL at DailyMed
Drug patent expirations by year for DRIXORAL
Synonyms for DRIXORAL
(+)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate
(+)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1)
(+)-2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine maleate
(+)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine maleate
(+)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
(+)-3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine maleate
(+)-Brompheniramine maleate
(+)-Brompheniramine maleate salt
(|AS)-|A-(4-bromophenyl)-N,N-dimethyl-2-pyridinepropanamine (2Z)-2-Butenedioate
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine; maleic acid
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine (2Z)-but-2-enedioate
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; (Z)-but-2-enedioic acid
(S)-1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane maleate
(S)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridinium (Z)-maleate (1:1)
(S)-2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine maleate
(S)-2-[p-Bromo-|A-[2-(dimethylamino)ethyl]benzyl]pyridine Maleate
(S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine maleate
(S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
(S)-3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine maleate
(S)-Brompheniramine Maleate
1-(p-Bromophenyl)-1-(2-pyridyl)-3-dimethylamine Propane Maleate
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1)
2391-03-9
AC-1161
AC1O5G0Y
AKOS015962824
Alahist IR
Alahist PE
AN-15187
B 5275
BC214876
BPA9UT29BS
Brompheniramine d-form maleate
C20H23BrN2O4
CAS-2391-03-9
CCG-101017
CHEBI:59273
CHEMBL1200638
CPD000471616
d-2-[p-Bromo-|A-(2-dimethylaminoethyl)benzyl]pyridine Maleate
d-Brompheniramine maleate
D03704
Dexbrompheniramine fumarate
DEXBROMPHENIRAMINE MALEATE
Dexbrompheniramine maleate (USAN)
Dexbrompheniramine maleate [USP]
Dexbrompheniramine maleate, United States Pharmacopeia (USP) Reference Standard
Dimegan
Disomer
Disomer (TN)
Disomer maleate
DSSTox_CID_27795
DSSTox_GSID_47818
DSSTox_RID_82567
DTXSID6047818
EINECS 219-236-2
EU-0100232
Halin
HMS2051F10
HMS2235O07
HMS3260P05
LP00232
MLS001401374
NC00267
NCGC00015146-11
NCGC00093697-01
NCGC00162100-02
NCGC00260917-01
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1), (S)-
SAM001246556
SCHEMBL217770
SMR000471616
SR-01000075719
SR-01000075719-1
Tox21_112000
Tox21_112000_1
Tox21_500232
UNII-BPA9UT29BS
UNII-IXA7C9ZN03 component SRGKFVAASLQVBO-DASCVMRKSA-N
W0027

US Patents and Regulatory Information for DRIXORAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering Plough DRIXORAL dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 013483-003 Sep 13, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Schering Plough DRIXORAL PLUS acetaminophen; dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 019453-001 May 22, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Johnson and Johnson
Baxter
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.